These outcomes, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two guidance the strategy of targeting ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Diseases. Publishing this overview signifies that https://diceg913zws4.ja-blog.com/profile